BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted) clinical trials

A Phase IV, open label, single arm trial to assess the safety and immunogenicity of BIMERVAX® LP.8.1 against SARS-CoV-2 variants.

This study is looking at a new COVID-19 vaccine, BIMERVAX LP.8.1, to see how safe it is and how well it helps your body fight off different types of the virus, especially Omicron. It's for people who've already had the vaccine (Phase IV).